Iguchi Kimi - Jan 4, 2023 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
CFO & Treasurer
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Kimi Iguchi
Stock symbol
SAGE
Transactions as of
Jan 4, 2023
Transactions value $
$2,448
Form type
4
Date filed
1/5/2023, 03:30 PM
Previous filing
Feb 18, 2022
Next filing
Jan 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Options Exercise $2.45K +1.8K +3.2% $1.36 58K Jan 4, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SAGE Stock Option (Right to Buy) Options Exercise $0 -1.8K -19.91% $0.00 7.24K Jan 4, 2023 Common Stock 1.8K $1.36 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects beneficial ownership balance which includes 427 shares purchased on June 30, 2022 and 197 shares purchased on December 31, 2022, each under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.
F2 The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.